| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/07/2013 | EP2621947A1 Compositions and methods for treating neoplasia |
| 08/07/2013 | EP2621531A1 Anti-cd38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma and nhl |
| 08/07/2013 | EP2621526A1 Antibody drug conjugates (adc) that bind to 191p4d12 proteins |
| 08/07/2013 | CN103237813A Antibody targeting osteoclast-elated protein Siglec-15 |
| 08/07/2013 | CN103237812A Anti-ephrin-B2 antibody and use thereof |
| 08/07/2013 | CN103237811A Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (LPR6) multivalent antibodies |
| 08/07/2013 | CN103237810A Anti-angiogenesis therapy for the treatment of ovarian cancer |
| 08/07/2013 | CN103237809A A collection and methods for its use |
| 08/07/2013 | CN103237807A Clostridium difficile antigens |
| 08/07/2013 | CN103235129A Marek's disease virus and subgroup-J avian leukosis virus rapid combined-detection test strip |
| 08/07/2013 | CN103233013A Nile tilapia transforming growth factor TGF-beta 1 gene, related protein and application |
| 08/07/2013 | CN103232975A Hybridoma cell strain 2D3, monoclonal antibody to zearalenone secreted by same and application of monoclonal antibody |
| 08/07/2013 | CN103232974A Hybridoma cell strain secreting high-neutralization activity infectious bursal disease virus (IBDV) monoclonal antibody |
| 08/07/2013 | CN103232541A Monoclonal antibodies against activated protein c |
| 08/07/2013 | CN103232540A Domain antibody construct |
| 08/07/2013 | CN103232539A Antibodies to opgl |
| 08/07/2013 | CN103232529A Epitope peptide |
| 08/07/2013 | CN103230784A Composite continuous bed cryogel and preparation thereof, and application in separating IgG and albumin |
| 08/07/2013 | CN102702357B Recombination cyclophilin A antibody, preparation method thereof, enzyme-linked immuno sorbent assay (ELISA) kit and cell strains |
| 08/07/2013 | CN102358754B Protein from RHBDD1 and use thereof in preparing monoclonal antibody for detecting colon and rectal cancer or breast cancer |
| 08/07/2013 | CN102321175B Nano-antibody or polypeptide aiming at breast cancer Her2/new |
| 08/07/2013 | CN102174540B Method for modifying plant morphology, biochemistry and physiology |
| 08/07/2013 | CN102060923B Monoclonal antibody for specifically identifying activated protein Gas and preparation method thereof |
| 08/07/2013 | CN101845438B Sensitive diagnosis and relative treatment for cancers through 20 tumor specific related genes and products |
| 08/07/2013 | CN101553506B Lingo binding molecules and pharmaceutical use thereof |
| 08/07/2013 | CN101395183B Anti-ephb4 antibodies and methods using same |
| 08/07/2013 | CN101379089B Anti-ilt7 antibody |
| 08/07/2013 | CN101312989B Monoclonal antibodies against claudin-18 for treatment of cancer |
| 08/06/2013 | US8502018 Methods of modifying eukaryotic cells |
| 08/06/2013 | US8502014 Method for the production of a single heavy chain antibody |
| 08/06/2013 | US8501917 Anti c-Met antibody and uses thereof |
| 08/06/2013 | US8501916 Antibodies to matrix metalloproteinase 9 |
| 08/06/2013 | US8501915 Regulatory T cell mediator proteins and uses thereof |
| 08/06/2013 | US8501427 Factor H polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration |
| 08/06/2013 | US8501415 Identification of TSH receptor autoantibodies using affinity-purified antibodies |
| 08/06/2013 | US8501399 Asymmetrically branched polymer conjugates and microarray assays |
| 08/06/2013 | US8501185 Dimeric molecular complexes |
| 08/06/2013 | US8501184 High affinity human antibodies to PCSK9 |
| 08/06/2013 | US8501183 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 08/06/2013 | US8501180 Anti system ASC amino acid transporter 2 (ASCT2) antibody |
| 08/06/2013 | US8501176 Methods of reducing eosinophil levels |
| 08/06/2013 | US8501175 TMPRSS4-specific human antibody |
| 08/06/2013 | US8501171 Use of ADCC-optimized antibodies for treating weak patients |
| 08/06/2013 | CA2844264A1 Optimized antigens of pneumocystis and use thereof |
| 08/06/2013 | CA2598253C Human ring specific bnp antibodies |
| 08/06/2013 | CA2526509C Connective tissue growth factor antibodies |
| 08/06/2013 | CA2521826C Recombinant il-9 antibodies and uses thereof |
| 08/06/2013 | CA2489214C Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 08/06/2013 | CA2371929C Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5 |
| 08/01/2013 | WO2013112945A1 Humanized antibodies that recognize alpha-synuclein |
| 08/01/2013 | WO2013112922A1 Composition and method for diagnosis and treatment of diseases associated with neurite degeneration |
| 08/01/2013 | WO2013112663A1 Myonectin (ctrp15), compositions comprising same, and methods of use |
| 08/01/2013 | WO2013112467A1 DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS |
| 08/01/2013 | WO2013112438A1 Stabilized formulations containing anti-ang2 antibodies |
| 08/01/2013 | WO2013112103A1 Method of detecting tuberculosis |
| 08/01/2013 | WO2013110946A1 Combined therapeutic use of antibodies and endoglycosidases |
| 08/01/2013 | WO2013110945A1 Methods of treating pain by inhibition of vgf activity |
| 08/01/2013 | WO2013110790A1 Vaccine compositions for hiv prevention and treatment |
| 08/01/2013 | WO2013110531A1 Sequences directed against hepatocyte growth factor (hgf) and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 08/01/2013 | WO2013059168A3 Espirito santo virus and methods for detecting and preventing infection with the same |
| 08/01/2013 | WO2013041846A3 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
| 08/01/2013 | WO2013021088A3 Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas |
| 08/01/2013 | WO2012064733A3 Antibody scaffold for homogenous conjugation |
| 08/01/2013 | WO2008028501A8 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 08/01/2013 | US20130198880 Mice expressing a limited immunoglobulin light chain repertoire |
| 08/01/2013 | US20130197214 Nanoparticle chains and Preparation Thereof |
| 08/01/2013 | US20130197202 Anti-cd80 antibody |
| 08/01/2013 | US20130197199 Antibody against human prostaglandin e2 receptor ep4 |
| 08/01/2013 | US20130197198 Removal Of High Molecular Weight Aggregates Using Hydroxyapatite Chromatography |
| 08/01/2013 | US20130197196 Protein production |
| 08/01/2013 | US20130196930 Polynucleotides encoding recombinant lubricin molecules and uses thereof |
| 08/01/2013 | US20130196922 Bnip3 isoforms and methods of use |
| 08/01/2013 | US20130196427 Cancer antigen peptides derived from wt1 |
| 08/01/2013 | US20130196412 Magi polynucleotides, polypetides, and antibodies |
| 08/01/2013 | US20130196379 Antibodies |
| 08/01/2013 | US20130196378 Human monoclonal antibody |
| 08/01/2013 | US20130196377 Protein complex and method of preparing same |
| 08/01/2013 | US20130196376 Method for the High Level Expression of Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Proteins and Their Purification |
| 08/01/2013 | US20130196354 Detection of Synthetic Cannabinoids |
| 08/01/2013 | US20130196314 Genes Differentially Expressed in Breast Cancer |
| 08/01/2013 | US20130195940 Method to inhibit recruitment of monocytes and macrophages by an icam-3 inhibitor |
| 08/01/2013 | US20130195908 Molecular Complex for Targeting Antigens Towards Cells Comprising Antigens and Uses Thereof for Vaccination |
| 08/01/2013 | US20130195895 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 08/01/2013 | US20130195890 Treatment of ms with goat serum |
| 08/01/2013 | US20130195881 Potent, stable and non-immunosuppressive anti-cd4 antibodies |
| 08/01/2013 | US20130195878 Anti-asic1 antibodies and uses thereof |
| 08/01/2013 | US20130195877 Treatment of cachexia by targeting interleukin-1 beta |
| 08/01/2013 | US20130195876 Human streptococcus pneumoniae antibodies and uses therefor |
| 08/01/2013 | US20130195875 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 08/01/2013 | US20130195872 Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof |
| 08/01/2013 | US20130195871 Dual variable domain immunoglobulins and uses thereof |
| 08/01/2013 | US20130195869 Anti-human ccr7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier |
| 08/01/2013 | US20130195867 Rna-coded antibody |
| 08/01/2013 | US20130195865 Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
| 08/01/2013 | US20130195864 Fgfr-fc fusion protein and use thereof |
| 08/01/2013 | US20130195861 Serum amyloid p-antibody fusion proteins |
| 08/01/2013 | US20130195860 Antibody targeting through a modular recognition domain |
| 08/01/2013 | US20130195850 Cd3 immunotherapeutics and uses thereof |
| 08/01/2013 | US20130195849 Stable Heterodimeric Antibody Design with Mutations in the Fc Domain |
| 08/01/2013 | US20130195847 Treatment with anti-vegf antibodies |